About Catalent
Catalent is a company based in Somerset (United States) founded in 2007 was acquired by Novo Holdings in February 2024.. Catalent has completed 13 acquisitions, including Accucaps, Bettera and Cook Pharmica. Catalent offers products and services including Oral Dose Development, Softgel Technology, and Inhalation Development. Catalent operates in a competitive market with competitors including Novartis, Surrozen, Curia, AmplifyBio and WuXi Biologics, among others.
- Headquarter Somerset, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Catalent, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$761.61 K (USD), Grant
Oct 01, 2020
-
Investors
JPMorgan Chase
& 3 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Accucaps
& 12 more
-
Acquired by
Novo Holdings
(Feb 05, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Catalent
Catalent offers a comprehensive portfolio of products and services, including Oral Dose Development, Softgel Technology, and Inhalation Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for formulating and enhancing oral drug bioavailability.
Encapsulation solutions for improved drug delivery and stability.
Analytical and formulation services for inhalable drug forms.
Unlock access to complete
Software Development Team
170 people
Leadership Team
60 people
Operations Team
46 people
Human Resources and Administration
31 people
Product Management Team
28 people
Senior Team
27 people
Legal and Compliance
23 people
Finance and Accounting
21 people
Unlock access to complete
Funding Insights of Catalent
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $761,612
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Grant - Catalent | Valuation |
investors |
|
| Feb, 2020 | Amount | Debt – Conventional - Catalent | Valuation |
investors |
|
| May, 2015 | Amount | Grant - Catalent | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Catalent
Catalent has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include JPMorgan Chase, European Union and Aisling Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Catalent
Catalent has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Accucaps, Bettera and Cook Pharmica. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Vaccine development is advanced by VMIC as a non-profit entity.
|
2018 | ||||
|
iPS cells are developed for therapeutics to prevent immune rejection.
|
2017 | ||||
|
Services for cell therapy development and manufacturing are provided.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Catalent
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Catalent Comparisons
Competitors of Catalent
Catalent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Surrozen, Curia, AmplifyBio and WuXi Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
|
| domain | founded_year | HQ Location |
Protein therapeutics are developed and manufactured by WuXi Biologics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Catalent
Frequently Asked Questions about Catalent
When was Catalent founded?
Catalent was founded in 2007.
Where is Catalent located?
Catalent is headquartered in Somerset, United States.
Who is the current CEO of Catalent?
Alessandro Maselli is the current CEO of Catalent.
What does Catalent do?
Catalent, backed by 202366937.14725998 from European Union, JPMorgan Chase, Aisling Capital, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and biologics. CDMO offering drug and biologics development services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Catalent?
What products or services does Catalent offer?
Catalent offers Oral Dose Development, Softgel Technology, and Inhalation Development.
How many acquisitions has Catalent made?
Catalent has made 13 acquisitions, including Accucaps, Bettera, and Cook Pharmica.
Who are Catalent's investors?
Catalent has 4 investors. Key investors include JPMorgan Chase, European Union, Aisling Capital, and Novo Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.